Cyber threats move faster than drug development, and that has changed the security challenge for pharmaceutical companies.

For life sciences organizations, cybersecurity is not only about protecting data. It also must safeguard research timelines, manufacturing continuity and regulatory activity across multiple regions. When security operations are fragmented, gaps in visibility and response can emerge just as threats become more coordinated, targeted and persistent.

That challenge was particularly acute for a global pharmaceutical company operating across 15 countries, where independent regional security teams had evolved over time. Each team monitored its own environment, used its own tools and followed its own processes. But cyber threats do not respect regional boundaries. When intelligence emerged in one market, teams in another could remain unaware of the same tactics, creating blind spots across the wider environment.

At the same time, the company had to protect highly sensitive research data, manufacturing systems and regulatory processes in a sector where disruption carries both commercial and patient impact. Research could not stop, manufacturing could not pause and compliance requirements remained non-negotiable.

Why pharmaceutical cybersecurity becomes harder when operations are fragmented

Pharmaceutical companies face a distinct mix of cybersecurity pressures. Intellectual property remains a high-value target, manufacturing environments often include legacy and operational technology systems, and regulatory oversight places additional demands on resilience and control.

For global organizations, these pressures become harder to manage when security teams operate independently across regions. Different tools, processes and response models can make it harder to detect patterns early or coordinate action quickly. A threat identified in one geography may have implications for another, but without shared visibility, those connections can be missed.

For this pharmaceutical company, that fragmentation had become a growing constraint. Security teams were working hard within their own regions, but the overall model no longer matched the speed or scale of the threat landscape. The business needed a more coordinated approach that could improve detection, strengthen response and support compliance across both IT and OT environments.

How a more unified security model took shape

The transformation focused on centralizing security operations, improving visibility across environments and creating a more coordinated response model across regions. To support this, the company partnered with HCLTech to help unify monitoring, standardize response processes and strengthen security operations at global scale. 

1. Centralized 24/7 security coverage

A centralized Security Operations Center created continuous monitoring across time zones, replacing a model based on separate regional schedules. This gave the organization a more consistent view of threats across the enterprise and reduced the risk of incidents being handled in isolation.

With 24/7 coverage in place, the security model became less dependent on where an issue appeared and more focused on how quickly it could be identified and addressed. 

2. Integrated visibility across IT and OT

The transformation also improved visibility across research, manufacturing and corporate environments by integrating monitoring across both IT and OT systems. This helped reduce blind spots and gave teams a better view of threats moving across the environment.

Threat intelligence relevant to the life sciences sector was incorporated into monitoring processes, helping the organization identify attack patterns more effectively. As a result, threat detection improved by 30%, enabling teams to respond earlier and with a better understanding of potential impact. 

3. Faster, more consistent response

Response processes were strengthened through greater automation and standardization. SOAR playbooks were introduced for common threat scenarios, helping contain issues more quickly and reducing the reliance on manual intervention during the earliest stages of an incident.

This contributed to a 30% improvement in response times, while also making remediation more consistent across regions. Repetitive tasks could be automated, allowing analysts to focus more attention on complex investigations and higher-priority risks. 

4. Compliance embedded into operations

For a pharmaceutical company, stronger security also had to work within the requirements of regulated environments. Compliance monitoring was therefore built more directly into day-to-day operations, rather than treated as a separate, manual exercise.

Across GxP-relevant environments, controls could be monitored continuously without disrupting production schedules. OT security monitoring relied on non-invasive approaches designed to reduce operational risk while still improving oversight. The organization maintained 99.9% uptime while strengthening security and compliance across the estate. 

5. Better coordination across regions

A more unified operating model also improved how threat intelligence was shared across geographies. When suspicious activity was identified in one region, teams elsewhere could act with the same information rather than waiting for local escalation. That helped create a more coordinated defensive posture across the wider environment.

This mattered not only for security teams, but for the broader business. Research teams needed secure collaboration, manufacturing operations needed continuity and regulatory work needed to stay on schedule. A more coordinated security model helped reduce the likelihood that incidents would disrupt those critical activities.

Why coordinated security matters in life sciences

For pharmaceutical organizations, cybersecurity has to do more than defend systems in isolation. It has to support the continuity of research, production and regulatory operations across a global business.

In this case, moving from fragmented regional teams to a more unified security operations model helped the company improve visibility, speed up response and strengthen compliance without interrupting the work those systems support. The monitoring, automation and intelligence behind that model may sit in the background, but they play a direct role in helping science, manufacturing and regulation continue at pace.

Read the full case study here.